Medicare Enrolled
Dr. Rukmini Menon, MD
Neurology · Raleigh, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Menon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Menon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Menon
Dr. Rukmini Menon is a neurology specialist in Raleigh, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Menon performed 18,571 Medicare services across 1,077 unique beneficiaries.
Between the years covered by Open Payments, Dr. Menon received a total of $13,699 from 71 pharmaceutical and/or device companies across 627 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Menon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 5% volume in NC
$13,699 industry payments
Medicare Practice Summary
Medicare Utilization ↗18,571
Medicare services
Top 5% in NC for neurology
1,077
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,032 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, natalizumab, 1 mg | 8,100 | $19 | $35 |
| MRI contrast dye injection (gadobutrol) | 5,490 | $0 | $2 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 3,290 | $38 | $90 |
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
586 | $24 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
260 | $87 | $220 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
148 | $121 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
121 | $113 | $380 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
92 | $34 | $834 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
62 | $48 | $228 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
57 | $16 | $166 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
52 | $62 | $194 |
| MRI of brain with and without contrast An MRI scan of the brain using contrast dye both before and after administration to provide detailed images of brain structures. |
47 | $146 | $2,235 |
| Nerve-muscle junction testing A diagnostic test used to evaluate the function of the connection between nerves and muscles. |
43 | $27 | $92 |
| New patient office visit, complex (60-74 min) | 43 | $140 | $430 |
| Central motor stimulation test of arms and legs This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs. |
39 | $91 | $284 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
37 | $11 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
37 | $61 | $150 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
36 | $94 | $510 |
| Needle electromyography of muscles A test that measures the electrical activity of muscles using a needle electrode. It helps evaluate muscle health and nerve function. |
16 | $32 | $111 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
15 | $455 | $1,150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
91.3% medium
7.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,699
Total received (2018-2024)
Avg $1,957/year across 7 years
Top 17% in NC for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
627
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,614 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$86 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,187
2023
$2,838
2022
$2,146
2021
$1,228
2020
$951
2019
$1,278
2018
$1,071
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$496
ABBVIE INC.
$404
Alexion Pharmaceuticals, Inc.
$269
JAZZ PHARMACEUTICALS INC.
$256
Neurocrine Biosciences, Inc.
$251
MDD US Operations, LLC
$233
Lundbeck LLC
$203
Lilly USA, LLC
$198
ARGENX US, INC.
$195
Genentech USA, Inc.
$189
Eisai Inc.
$151
PFIZER INC.
$145
Inspire Medical Systems, Inc.
$110
Biogen, Inc.
$107
HARMONY BIOSCIENCES LLC
$102
Avadel CNS Pharmaceuticals, LLC
$98
Amgen Inc.
$95
Harmony Biosciences Llc
$67
Teva Pharmaceuticals USA, Inc.
$60
Axsome Therapeutics, Inc.
$57
Acorda Therapeutics, Inc
$54
Novartis Pharmaceuticals Corporation
$53
SK Life Science, Inc.
$51
Neurelis, Inc.
$49
ANI Pharmaceuticals, Inc.
$45
TG Therapeutics, Inc.
$36
Alnylam Pharmaceuticals Inc.
$36
CATALYST PHARMACEUTICALS, INC.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$31
ACADIA Pharmaceuticals Inc
$30
CSL Behring
$29
Ultragenyx Pharmaceutical Inc.
$21
Celgene Corporation
$20
Ipsen Biopharmaceuticals, Inc
$15
Top 3 companies account for 27.9% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,199
Alexion Pharmaceuticals, Inc.
$1,123
Teva Pharmaceuticals USA, Inc.
$1,088
ABBVIE INC.
$728
JAZZ PHARMACEUTICALS INC.
$535
Neurocrine Biosciences, Inc.
$528
Novartis Pharmaceuticals Corporation
$505
Supernus Pharmaceuticals, Inc.
$504
MDD US Operations, LLC
$446
ARGENX US, INC.
$322
Lundbeck LLC
$320
Amgen Inc.
$305
Genentech USA, Inc.
$302
Neurelis, Inc.
$264
Lilly USA, LLC
$256
Merz North America, Inc.
$251
Jazz Pharmaceuticals Inc.
$242
Sunovion Pharmaceuticals Inc.
$242
HARMONY BIOSCIENCES LLC
$234
PFIZER INC.
$213
SK Life Science, Inc.
$211
Eisai Inc.
$204
Grifols USA, LLC
$190
US WorldMeds, LLC
$181
Acorda Therapeutics, Inc
$170
IMPEL PHARMACEUTICALS INC.
$159
Avion Pharmaceuticals
$158
Biogen, Inc.
$157
Merz Pharmaceuticals, LLC
$143
Averitas Pharma Inc.
$123
AbbVie, Inc.
$121
CSL Behring
$117
Harmony Biosciences LLC
$117
Allergan Inc.
$115
TG THERAPEUTICS, INC.
$114
Inspire Medical Systems, Inc.
$110
Horizon Therapeutics plc
$98
Avadel CNS Pharmaceuticals, LLC
$98
ARBOR PHARMACEUTICALS, INC.
$97
LivaNova USA, Inc.
$96
Axsome Therapeutics, Inc.
$85
Amneal Pharmaceuticals LLC
$72
Celgene Corporation
$69
ACADIA Pharmaceuticals Inc
$68
Harmony Biosciences Llc
$67
Mallinckrodt LLC
$64
Janssen Pharmaceuticals, Inc
$63
Mitsubishi Tanabe Pharma America, Inc.
$63
AQUESTIVE THERAPEUTICS, INC.
$61
GENZYME CORPORATION
$56
Alnylam Pharmaceuticals Inc.
$54
Sumitomo Pharma America, Inc.
$53
MERZ NORTH AMERICA, INC.
$51
Ipsen Biopharmaceuticals, Inc
$49
ANI Pharmaceuticals, Inc.
$45
TG Therapeutics, Inc.
$36
Microtransponder, Inc.
$35
Collegium Pharmaceutical, Inc.
$33
CATALYST PHARMACEUTICALS, INC.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$31
Biohaven Pharmaceutical Holding Company Ltd.
$25
GE HealthCare
$25
Corium, LLC
$23
Banner Life Sciences, LLC
$22
Otsuka America Pharmaceutical, Inc.
$22
Catalyst Pharmaceuticals, Inc.
$21
Ultragenyx Pharmaceutical Inc.
$21
Octapharma USA, Inc.
$19
Mallinckrodt Enterprises LLC
$18
IDORSIA PHARMACEUTICALS US INC
$14
EMD Serono, Inc.
$14
Top 3 companies account for 24.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRIUMVI · Bidil · Briviact · COPAXONE · DUOPA · Dhivy · Dojolvi · Duopa · Dysport · ELYXYB - celecoxib · EMGALITY · Enspryng · FIRDAPSE · Fycompa · GOCOVRI · Gamunex-C · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KISUNLA · KYNMOBI · LEQEMBI · LUMRYZ · LYVISPAH · Leqembi · NORTHERA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PURIFIED CORTROPHIN GEL · QULIPTA · QUTENZA · QUVIVIQ · REXULTI · RYTARY · Radicava · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Soliris · Sunosi · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XCOPRI · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · Xyrem · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
115
Per 100K population
10.0
County median income
$101,763
Nearest hospital
REX HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Menon is a mixed practice specialist, with above-average Medicare volume (top 5% in NC), with low-engagement industry engagement in the top 17% of NC peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Menon experienced with injection, natalizumab, 1 mg?
Based on Medicare claims data, Dr. Menon performed 8,100 injection, natalizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Menon receive payments from pharmaceutical companies?
Yes. Dr. Menon received a total of $13,699 from 71 companies across 627 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Menon's costs compare to other neurologists in Raleigh?
Dr. Menon's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Menon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Raleigh
Browse neurologists in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NC
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NC
Which NC neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology